367 related articles for article (PubMed ID: 8162655)
1. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
Olkkola KT; Brunetto AV; Mattila MJ
Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
[TBL] [Abstract][Full Text] [Related]
2. The influence of cholestyramine on the elimination of tenoxicam and piroxicam.
Guentert TW; Defoin R; Mosberg H
Eur J Clin Pharmacol; 1988; 34(3):283-9. PubMed ID: 3260866
[TBL] [Abstract][Full Text] [Related]
3. Plasma tenoxicam concentrations after single and multiple oral doses.
Crevoisier C; Heizmann P; Forgo I; Dubach UC
Eur J Drug Metab Pharmacokinet; 1989; 14(1):23-7. PubMed ID: 2788089
[TBL] [Abstract][Full Text] [Related]
4. Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam.
Benveniste C; Striberni R; Dayer P
Eur J Clin Pharmacol; 1990; 38(6):547-9. PubMed ID: 2373127
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.
Verbeeck RK
Clin Pharmacokinet; 1990 Jul; 19(1):44-66. PubMed ID: 2199127
[TBL] [Abstract][Full Text] [Related]
6. Disposition of ampiroxicam, a prodrug of piroxicam, in man.
Falkner FC; Twomey TM; Borgers AP; Garg D; Weidler D; Gerber N; Browder IW
Xenobiotica; 1990 Jun; 20(6):645-52. PubMed ID: 2219958
[TBL] [Abstract][Full Text] [Related]
7. The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage renal disease.
al-Ghamdi MS; al-Mohanna FA; al-Mustafa ZH; al-Saeed IS
Eur J Clin Pharmacol; 1992; 43(2):197-9. PubMed ID: 1425878
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of isoxicam in hepatic disease.
Ferry N; Cuisinaud G; Ouzan D; Trepo C; Sassard J
Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):143S-147S. PubMed ID: 2887185
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
Day RO; Williams KM; Graham S; Handel M
Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
[TBL] [Abstract][Full Text] [Related]
10. Cross-over study of the bioavailability of a new NSAID (droxicam) versus piroxicam in healthy volunteers following single and multiple dose administration.
Bartlett A; Costa A; Martinez L; Roser R; Sagarra R; Sanchez J
Eur J Drug Metab Pharmacokinet; 1992; 17(3):195-9. PubMed ID: 1490488
[TBL] [Abstract][Full Text] [Related]
11. Tenoxicam used as a parenteral formulation for acute pain in rheumatic conditions.
Jeunet F; Enz W; Guentert T
Scand J Rheumatol Suppl; 1989; 80():59-61. PubMed ID: 2595344
[TBL] [Abstract][Full Text] [Related]
12. Effect of age on the pharmacokinetics of tenoxicam in comparison to other non-steroidal anti-inflammatory drugs (NSAIDs).
Schmitt M; Guentert TW
Scand J Rheumatol Suppl; 1989; 80():86-9. PubMed ID: 2688082
[TBL] [Abstract][Full Text] [Related]
13. Tenoxicam concentrations in synovium and joint cartilage in humans.
Bannwarth B; Netter P; Lapicque F; Mainard D; Fener P; Gillet P; Gaucher A
Agents Actions; 1991 Mar; 32(3-4):295-8. PubMed ID: 1862747
[TBL] [Abstract][Full Text] [Related]
14. Influence of liver cirrhosis upon the pharmacokinetics of tenoxicam.
Crevoisier C; Zaugg PY; Heizmann P; Meyer J
Int J Clin Pharmacol Res; 1989; 9(5):327-34. PubMed ID: 2625372
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetic studies with lornoxicam.
Turner P; Johnston A
Postgrad Med J; 1990; 66 Suppl 4():S28-9. PubMed ID: 2284218
[TBL] [Abstract][Full Text] [Related]
16. Chlortenoxicam pharmacokinetics in young and elderly human volunteers.
Ankier SI; Brimelow AE; Crome P; Johnston A; Warrington SJ; Turner P; Ferber HP
Postgrad Med J; 1988 Oct; 64(756):752-4. PubMed ID: 3255915
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of lornoxicam in man.
Hitzenberger G; Radhofer-Welte S; Takacs F; Rosenow D
Postgrad Med J; 1990; 66 Suppl 4():S22-7. PubMed ID: 2284217
[TBL] [Abstract][Full Text] [Related]
18. The effect of concomitantly administered antacids on the bioavailability of lornoxicam, a novel highly potent NSAID.
Dittrich P; Radhofer-Welte S; Magometschnigg D; Kukovetz WR; Mayerhofer S; Ferber HP
Drugs Exp Clin Res; 1990; 16(2):57-62. PubMed ID: 2401187
[TBL] [Abstract][Full Text] [Related]
19. Metabolic disposition of the non-steroidal anti-inflammatory agent isoxicam in man.
Woolf TF; Black A; Sedman A; Chang T
Eur J Drug Metab Pharmacokinet; 1992; 17(1):21-7. PubMed ID: 1499594
[TBL] [Abstract][Full Text] [Related]
20. Oxicam-induced photosensitivity. Patch and photopatch testing studies with tenoxicam and piroxicam photoproducts in normal subjects and in piroxicam-droxicam photosensitive patients.
Serrano G; Fortea JM; Latasa JM; SanMartin O; Bonillo J; Miranda MA
J Am Acad Dermatol; 1992 Apr; 26(4):545-8. PubMed ID: 1597539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
